
|Videos|November 4, 2021
Glucose-Lowering Agents Nothing Short of Beneficial for Advanced CKD Patients
Galindo explained how the use of glucose-lowering agents in patients with diabetes and low eGFR improved patient care.
Advertisement
Pharmacy Times spoke to Rodolfo Galindo, MD, associate professor at the Emory School of Medicine, about his session at the ASN 2021 conference titled "Use of Glucose-Lowering Agents and Glycemic Monitoring in Advanced CKD.”
Galindo explained how the use of glucose-lowering agents in patients with diabetes and low eGFR improved patient care.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Inhaled Insulin Demonstrates Comparable Safety, Lung Function, and Efficacy to Injectable Insulin in Type 1 Diabetes
2
From $200,000 in Student Loan Debt to Becoming a 7-Figure Pharmacist
3
CDC Layoffs Raise Questions About the Future of Public Health Surveillance
4
Mind the Gap: Pharmacy’s Future as AI Evolves in Health Care
5